Long-term Survival after Hormonal Therapy for Stage D Prostatic Cancer

Abstract
Hormonal therapy occasionally produces long-term survival of men with metastatic carcinoma of the prostate. To identify which patients will benefit for long intervals a retrospective analysis was done on 56 men with stage D carcinoma of the prostate treated [estrogen therapy and orchiectomy] between 1963 and 1968. Of this group 5 patients lived longer than 10 yr. Clinical or pathologic characteristics that would have indicated which patients would have done well could not be identified.